MoonLake Immunotherapeutics
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Equivalents | $334.5M | $180.4M | $451.2M | $39.5M | $8.0M | $1.3M |
| Accounts Receivable | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — |
| Total Current Assets | $421.7M | $474.3M | $514.2M | $76.5M | $9.6M | $1.6M |
| Property, Plant & Equipment | $577.0K | $722.0K | $320.9K | $49.4K | $45.7K | — |
| Goodwill | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | $5.0M |
| Total Assets | $424.4M | $477.9M | $526.5M | $76.8M | $9.7M | $116.6M |
| Liabilities | ||||||
| Accounts Payable | — | — | — | — | — | — |
| Total Current Liabilities | $45.5M | $22.5M | $10.0M | $7.7M | $21.1M | $125.2K |
| Long-Term Debt | $74.1M | $0 | — | — | — | — |
| Total Liabilities | $120.0M | $24.5M | $13.0M | $8.1M | $21.3M | $4.2M |
| Stockholders' Equity | ||||||
| Retained Earnings | $-462.9M | $-235.6M | $-116.7M | $-80.7M | $-53.6M | $-2.5M |
| Total Stockholders' Equity | $304.5M | $446.8M | $495.7M | $48.9M | $-11.6M | $-2.5M |